Efficacy of Intrapleural or Intrapericardial Injection of Single Bevacizumab in the Treatment of Lung Cancer-Mediated Malignant Effusion.
Journal Information
Full Title: Can Respir J
Abbreviation: Can Respir J
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pulmonary Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of Interest The authors declare that they have no conflicts of interest."
"This prospective, open-labeled, single-arm, phase II clinical trial was performed at the First Affiliated Hospital of Guangzhou Medical University, China. All patients provided written informed consent prior to study-specific procedures. This study is registered with the Clinical Trail.gov Protocol Registration and Results System (PRS), under number NCT02054052. Data Availability: This study is registered with the Clinical Trail.gov Protocol Registration and Results System (PRS), under number NCT02054052."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025